Loss of E-cadherin in the vicinity of necrosis in colorectal carcinomas: association with NFkappaB expression.
暂无分享,去创建一个
[1] Charles James Kirkpatrick,et al. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. , 2007, International journal of molecular medicine.
[2] G. Sonenshein,et al. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. , 2006, Cancer research.
[3] Ximing Xu,et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. , 2004, World journal of gastroenterology.
[4] B. Aggarwal,et al. Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.
[5] Michael T. Lotze,et al. Inflammation and necrosis promote tumour growth , 2004, Nature Reviews Immunology.
[6] C. Sheehan,et al. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] Masao Tanaka,et al. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. , 2004, Anticancer research.
[8] T. Lightfoot,et al. Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. , 2003, Carcinogenesis.
[9] C. Kirkpatrick,et al. Effect of pro-inflammatory stimuli on tumor cell-mediated induction of endothelial cell adhesion molecules in vitro. , 2002, Experimental and molecular pathology.
[10] M. Tsuneyoshi,et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] J. Wang,et al. Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of beta-1 integrin expression. , 2001, The Journal of surgical research.
[12] J. Puzas,et al. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. , 2000, Cancer research.
[13] Maria Teresa Santini,et al. Three-Dimensional Spheroid Model in Tumor Biology , 1999, Pathobiology.
[14] S. Hirohashi. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. , 1998, The American journal of pathology.
[15] M. Karin. Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.
[16] Michael Karin,et al. NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.
[17] M. Karin,et al. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. , 2004, Cancer cell.
[18] A. Bosserhoff,et al. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. , 2004, Oncogene.
[19] Henning Schrader,et al. Increased expression of nuclear factor-κB/RelA is correlated with tumor angiogenesis in human colorectal cancer , 2003, International Journal of Colorectal Disease.
[20] S. Evertsson,et al. Protein expression of NF-kappaB in human colorectal adenocarcinoma. , 2002, International journal of molecular medicine.
[21] C. Bucana,et al. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. , 2001, Oncogene.
[22] J. Abbruzzese,et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] D. Baltimore,et al. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. , 1986, Cell.
[24] C. Kirkpatrick,et al. Reduced expression of TLR 4 is associated with the metastatic status of human colorectal cancer , 2022 .